Lingotto Investment Management LLP Sells 199,116 Shares of Oscar Health, Inc. $OSCR

Lingotto Investment Management LLP trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR) by 52.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 180,000 shares of the company’s stock after selling 199,116 shares during the quarter. Lingotto Investment Management LLP’s holdings in Oscar Health were worth $3,859,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Marshall Wace LLP acquired a new position in Oscar Health during the 2nd quarter worth $626,000. Annandale Capital LLC acquired a new position in Oscar Health during the 2nd quarter valued at about $965,000. First Trust Advisors LP boosted its stake in shares of Oscar Health by 6.8% in the 2nd quarter. First Trust Advisors LP now owns 292,310 shares of the company’s stock valued at $6,267,000 after purchasing an additional 18,627 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Oscar Health by 3.2% in the 2nd quarter. Invesco Ltd. now owns 252,781 shares of the company’s stock valued at $5,420,000 after purchasing an additional 7,801 shares during the last quarter. Finally, Blueshift Asset Management LLC acquired a new stake in shares of Oscar Health during the 2nd quarter worth approximately $1,194,000. 75.70% of the stock is owned by institutional investors.

Insider Activity at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the completion of the transaction, the insider directly owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 739,472 shares of company stock worth $12,616,880 over the last ninety days. 24.39% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

OSCR has been the topic of several analyst reports. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $13.00 to $25.00 in a report on Tuesday, November 25th. Wells Fargo & Company dropped their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. The Goldman Sachs Group began coverage on Oscar Health in a research note on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. Finally, Barclays increased their target price on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research note on Monday, November 10th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $14.86.

Oscar Health Stock Up 0.4%

NYSE:OSCR opened at $17.17 on Friday. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80. The stock has a 50-day moving average price of $18.06 and a two-hundred day moving average price of $16.94. The stock has a market cap of $4.55 billion, a price-to-earnings ratio of -15.33 and a beta of 1.88. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. Oscar Health’s revenue for the quarter was up 23.2% on a year-over-year basis. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.